What is Amniotic Products Market?
Amniotic products have been gaining interest in the past decade for the treatment of various orthopedic conditions. However, the use of biologics is varied and is currently available with minimal oversight or regulation. The growing target patient population and the rise in venture capital funding and government investments are the major factors boosting the growth of this market. The presence of a well-established healthcare system and ongoing investments by hospitals to upgrade & expand their operating capabilities are other factors supporting market growth.
The market study is being classified by Type (Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes) and Amniotic Suspensions), by Application (Wound Care, Orthopedics, Ophthalmology and Others) and major geographies with country level break-up.
iMedx (United States), Smith & Nephew (United Kingdom), Organogenesis (United States), Integra LifeSciences Corporation (United States), Other players include Stryker Corporation (United States), Wright Medical (Netherlands), Applied Biologics (United States), Celularity (United States), Katena Products (United States), Lucina BioSciences (United States), Next Biosciences (South Africa), Skye Biologics (United States) and Surgenex (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are TissueTech (United States), Ventris Medical (United States), StimLabs (United States), VIVEX Biologics (United States) and LifeCell International (India).
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Amniotic Products market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Amniotic Products market by Type, Application and Region.
On the basis of geography, the market of Amniotic Products has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing Awareness among the People regarding the Prevalence of Wound Care Treatment and Management
- Rising Incidence of Burn Injuries
- Adoption of Advanced Technologies
- Limitations associated with the Usage of Amniotic Membrane
- Rise in Venture Capital Investment and Government Funding
- Growth Potential in Emerging Market
- Complications associated with the Use of Amniotic Membranes
Market Leaders and some development strategies
In Aug. 11, 2020, BioStem Technologies, Inc. announced that its subsidiary, Blue Tech Industries, Inc. (doing business as BioStem Life Sciences), has signed a Master Service Agreement with a new customer to manufacture the customerís amniotic membrane platform for the next two years.
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Amniotic Products Manufacturer, Amniotic Products Suppliers/Distributors, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industry
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase